Seborrheic Dermatitis Treatment Market Scope Analysis 2020-2027

Author : Dipak Gaikwad | Published On : 04 May 2021

Seborrheic Dermatitis Treatment Market is expected to cross USD 3.28 Billion by 2025 at a CAGR of 10.5 %.

Market Synopsis

Seborrheic dermatitis is a chronic inflammatory disorder that mostly affects the head and face. Primarily environmental, genetic, and general health problems are the cause of this disorder. The exact cause of seborrheic dermatitis remains unknown, but factors such as a change in hormone is the primary cause of this disease. It frequently affects people post-puberty. The prevalence of seborrheic dermatitis has been rising significantly in recent years. In the US alone, approximately 300 people are diagnosed with seborrheic dermatitis annually making it a reasonably common dermatological disorder worldwide. Some factors influencing the market growth are the rising awareness of personal hygiene, advancement in treatment options for seborrheic dermatitis, and growing awareness regarding seborrheic dermatitis.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8499

The global seborrheic dermatitis treatment market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of seborrheic dermatitis and rising per capita healthcare expenditure. The seborrheic dermatitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European seborrheic dermatitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The seborrheic dermatitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of skin disorder and raising awareness about seborrheic dermatitis, the market in Asia-Pacific is expected to be the fastest-growing. The seborrheic dermatitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The global seborrheic dermatitis treatment market has been segmented based on treatment type, route of administration, and end user.

The market, based on treatment type, has been divided into antifungal products, corticosteroid lotions, and sulfur products. Around 1.5 million Americans are diagnosed with various seborrheic dermatitis every year. The corticosteroid lotions segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the pediatric population.

The global seborrheic dermatitis treatment market has been segmented, on the basis of route of administration, oral, and topical. The oral segment is expected to hold the majority share of the market. Around 25 million adults are diagnosed with chronic seborrheic dermatitis every year, and most of them treated with the help of oral drugs. The topical segment is expected to be the fastest-growing due to its increasing use globally. It was estimated that around 1.3 million people in the US were afflicted with seborrheic dermatitis in 2018.

The end-user segments of the market are hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services.

Key Players

Some of the key players in the Global Seborrheic Dermatitis Treatment Market are Sonoma Pharmaceuticals (US), Merck (US), Hikma Pharmaceuticals (UK), Allen and Hanburys (UK), GlaxoSmithKline (UK), Bausch Health (Canada), Valent Pharmaceutical (UK), and West-Ward Pharmaceutical Corp. (US).

 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com